المؤلفون: Wu C; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Zhang Z; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Bai L; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Lei S; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Zou M; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Bao Z; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Ren Z; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Liu K; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China., Gong HH; School of Biomedical Engineering and Medical Imaging, Hubei University of Science and Technology, XianNing, Hubei Province, 437000, China. Electronic address: ghhemily@outlook.com., Ma W; Arura Tibetan Medicine Co., Ltd., State Key Laboratory of Tibetan Medicine Research and Development, Xining, China. Electronic address: 345199603@qq.com., Chen L; School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China. Electronic address: clyhappy05@163.com.

المصدر: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Aug 10; Vol. 330, pp. 118254. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7573 (Electronic) Linking ISSN: 03788741 NLM ISO Abbreviation: J Ethnopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Piper*/chemistry , Gout*/drug therapy , Proto-Oncogene Proteins c-akt*/metabolism , Plant Extracts*/pharmacology , Plant Extracts*/chemistry , Plant Extracts*/therapeutic use , Phosphatidylinositol 3-Kinases*/metabolism, Animals ; Mice ; Male ; Molecular Docking Simulation ; Signal Transduction/drug effects ; Network Pharmacology ; Hyperuricemia/drug therapy ; Mice, Inbred C57BL ; Gout Suppressants/pharmacology ; Gout Suppressants/therapeutic use ; Gout Suppressants/isolation & purification ; Fruit/chemistry ; Disease Models, Animal ; MAP Kinase Signaling System/drug effects ; Mitogen-Activated Protein Kinases/metabolism

عنوان ترانسليتريتد: La gota, más allá de la articulación: ¿cómo debemos tratarla?

المؤلفون: Pou MA; EAP Encants, Institut Català de la Salut, Barcelona, España; Grupo de Investigación en Enfermedades del Aparato Locomotor en Atención Primaria (GREMPAL)., Martinez-Laguna D; Grupo de Investigación en Enfermedades del Aparato Locomotor en Atención Primaria (GREMPAL); CAP Sant Martí de Provençals, Institut Català de la Salut, Barcelona, España., Diaz-Torne C; Grupo de Investigación en Enfermedades del Aparato Locomotor en Atención Primaria (GREMPAL); Servei de Reumatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, España; Grupo de Estudio de Artropatías Cristalinas de la Sociedad Española de Reumatología (GEACSER). Electronic address: cesardiaztorne@gmail.com.

المصدر: Semergen [Semergen] 2024 Jul-Aug; Vol. 50 (5), pp. 102176. Date of Electronic Publication: 2024 Feb 01.

نوع المنشور: Journal Article; Review; English Abstract

بيانات الدورية: Publisher: Saned, S.A Country of Publication: Spain NLM ID: 9610769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8865 (Electronic) Linking ISSN: 11383593 NLM ISO Abbreviation: Semergen Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/therapy , Gout*/diagnosis , Hyperuricemia*/therapy , Hyperuricemia*/diagnosis , Hyperuricemia*/etiology, Humans ; Uric Acid/blood ; Uric Acid/metabolism ; Spain ; Patient Education as Topic ; Life Style ; Gout Suppressants/therapeutic use ; Prevalence ; Diet ; Risk Factors ; Incidence ; Medication Adherence ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/therapy

المؤلفون: Selvadurai D; St Vincent's Healthcare Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, Australia., Coleshill MJ; Black Dog Institute, Sydney, Australia.; UNSW Medicine & Health, UNSW Sydney, Sydney, Australia., Day RO; St Vincent's Healthcare Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, Australia., Briggs NE; Stats Central, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney, Australia., Schulz M; St Vincent's Healthcare Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, Australia., Reath J; Department of General Practice, Western Sydney University, Sydney, Australia., Aung E; St Vincent's Healthcare Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, Australia.; Kolling Institute of Medical Research, Pain Management Research Institute, University of Sydney, Sydney, Australia.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Jul 01; Vol. 63 (7), pp. 1927-1937.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/psychology , Gout*/drug therapy , Quality of Life* , Medication Adherence*/psychology, Humans ; Male ; Female ; Middle Aged ; Aged ; Gout Suppressants/therapeutic use ; Surveys and Questionnaires ; Symptom Flare Up ; Uric Acid/blood ; Adult ; Age Factors ; Patient Acceptance of Health Care/psychology

المؤلفون: Siegel J; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Thanh Hai M; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Stein P; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

المصدر: JAMA [JAMA] 2024 Sep 17; Vol. 332 (11), pp. 934-935.

نوع المنشور: Letter

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/blood , Gout*/diagnosis , Gout*/drug therapy , Uric Acid*/blood, Humans ; Biomarkers/blood ; Chronic Disease/drug therapy ; Gout Suppressants/therapeutic use ; Treatment Outcome

المؤلفون: Richette P; Department of Rheumatology, Lariboisière Hospital, Paris, France., Dalbeth N; Department of Medicine, University of Auckland, Auckland, New Zealand., Stamp LK; Department of Medicine, University of Otago, Christchurch, New Zealand.

المصدر: JAMA [JAMA] 2024 Sep 17; Vol. 332 (11), pp. 935-936.

نوع المنشور: Letter

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/blood , Gout*/diagnosis , Gout*/drug therapy , Uric Acid*/blood, Humans ; Biomarkers/blood ; Chronic Disease/drug therapy ; Treatment Outcome ; Gout Suppressants/therapeutic use

المؤلفون: Wallach JD; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia., Ramachandran R; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Ross JS; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Deputy Editor, JAMA.

المصدر: JAMA [JAMA] 2024 Sep 17; Vol. 332 (11), pp. 936-937.

نوع المنشور: Letter

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/blood , Gout*/diagnosis , Gout*/drug therapy , Uric Acid*/blood, Humans ; Biomarkers/blood ; Chronic Disease/drug therapy ; Gout Suppressants/therapeutic use ; Treatment Outcome

المؤلفون: Gurney M; Otorhinolaryngology, Swansea Bay University Health Board, Port Talbot, UK Megan.gurney1990@gmail.com., Morris S; Morriston Hospital, Carmarthen, UK., Saw K; Otorhinolaryngology, Swansea Bay University Health Board, Port Talbot, UK.

المصدر: BMJ case reports [BMJ Case Rep] 2024 Aug 30; Vol. 17 (8). Date of Electronic Publication: 2024 Aug 30.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/pathology , Gout*/diagnosis, Humans ; Male ; Ear Auricle/pathology ; Gout Suppressants/therapeutic use ; Middle Aged

المؤلفون: Yang X; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Li Y; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Pan S; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Ma F; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Chen H; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Deng J; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Yue J; Laboratory of Drug Design and Discovery, Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China., Gong Q; Laboratory of Drug Design and Discovery, Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China., Zheng M; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Zeng Y; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Li J; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Zhang Y; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Wang X; HEC Pharm Group, HEC Research and Development Center, Dongguan 523871, China., Zhang X; Laboratory of Drug Design and Discovery, Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China.

المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Aug 22; Vol. 67 (16), pp. 14668-14691. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Xanthine Oxidase*/antagonists & inhibitors , Xanthine Oxidase*/metabolism , Hyperuricemia*/drug therapy , Gout*/drug therapy , Organic Anion Transporters*/antagonists & inhibitors , Organic Anion Transporters*/metabolism , Organic Cation Transport Proteins*/antagonists & inhibitors , Organic Cation Transport Proteins*/metabolism, Animals ; Structure-Activity Relationship ; Humans ; Rats ; Administration, Oral ; Rats, Sprague-Dawley ; Male ; Macaca fascicularis ; Febuxostat/pharmacology ; Febuxostat/pharmacokinetics ; Febuxostat/therapeutic use ; Febuxostat/chemistry ; Drug Discovery ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/pharmacokinetics ; Enzyme Inhibitors/therapeutic use ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/chemical synthesis ; Gout Suppressants/pharmacokinetics ; Gout Suppressants/pharmacology ; Gout Suppressants/therapeutic use ; Gout Suppressants/chemistry ; Gout Suppressants/chemical synthesis ; Biological Availability ; Probenecid/pharmacology

المؤلفون: Ebstein E; Rheumatology Department, Université Paris Cité, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75018, Paris, France., Ottaviani S; Rheumatology Department, Université Paris Cité, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75018, Paris, France. sebastien.ottaviani@aphp.fr.

المصدر: Drugs & aging [Drugs Aging] 2024 Aug; Vol. 41 (8), pp. 653-663. Date of Electronic Publication: 2024 Jul 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/drug therapy , Gout*/complications , Metabolic Syndrome*/complications, Humans ; Gout Suppressants/therapeutic use ; Cardiovascular Diseases/etiology ; Hyperuricemia/drug therapy ; Hyperuricemia/complications

المؤلفون: Li J; Heilongjiang University of Chinese Medicine, Harbin, China., Zhang Y; Harbin Institute of Technology, Harbin, China., Fu T; Brandeis University, Waltham, MA, United States., Xing G; First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China., Tong Y; First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address: tongying@hljucm.edu.cn.

المصدر: Pharmacological research [Pharmacol Res] 2024 Sep; Vol. 207, pp. 107319. Date of Electronic Publication: 2024 Jul 18.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/drug therapy, Humans ; Clinical Trials as Topic ; Gout Suppressants/therapeutic use ; Kidney Diseases/drug therapy ; Uric Acid/metabolism ; Uric Acid/blood